Aldeyra Therapeutics (ALDX) traded up 0.78 % during a 24 hours period ending at 10:33 PM Central Europe on Monday 26th. One Aldeyra Therapeutics stock can currently be bought for about USD 0.64 on popular exchanges. Current supply of Aldeyra Therapeutics stocks is 60.3 mn. Aldeyra Therapeutics has a current market capitalization of USD 39.2 mn and approximately USD 534 k worth of Aldeyra Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Aldeyra Therapeutics has traded -46.72 % down. Simple moving average of last 200 days is at USD 2.37. The highest price of past 52 weeks was recorded at USD 5.93 on 01/30/2026. 52 weeks low was at USD 0.6 on 10/23/2026.
Here is how related stocks have performed in the past 24 hours:
Culp (CULP) traded down -1.67 % and now trades at USD 3.54. Current market capitalisation for Culp is USD 45.1 mn.
Spectral Ai (MDAI) traded down -4 % and now trades at USD 1.5. Spectral Ai has a market capitalisation of USD 46.3 mn.
Air Water Ventures (WATR) traded down -5.23 % and now trades at USD 1.44. Current market capitalisation for Air Water Ventures is USD 45.9 mn.
Ibio (IBIO) traded down -7.69 % and now trades at USD 0.71. Ibio has a market capitalisation of USD 46.2 mn.
Bgsf (BGSF) traded up 4.56 % and now trades at USD 4.35. Bgsf has a market capitalisation of USD 46.5 mn.
About Aldeyra Therapeutics
Aldeyra Therapeutics, Inc. is a health care biotechnology company based in Lexington, United States. The company specializes in providing medical services for the treatment and research of dry eye disease, allergic conjunctivitis, and other forms of ocular inflammation.